Loading clinical trials...
Loading clinical trials...
The main purpose of this study is to develop sensitive radiographic measurement techniques that can be used as outcome measures along with patient-reported outcome instruments in clinical trials of ca...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Yale University
Collaborators
NCT06655155 · Systemic Sclerosis (SSc)
NCT07526350 · Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies, and more
NCT07413341 · Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome (SS), and more
NCT07305116 · Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), and more
NCT06991114 · Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), and more
Yale Scleroderma Program
New Haven, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions